PLAT and neoplasm: Indeed, treatment with a tissue plasminogen activator, a thrombolytic agent, could successfully deplete fibrin deposition, reopen the compressed tumor vessels, improve tumor blood flow, and further enhance the accumulation and penetration of nanotherapeutics [40].